Abstract:Secondary metabolites produced by Bacillus species from marine sources encompass a variety of compounds such as lipopeptides, isocoumarins, polyketides, macrolactones, polypeptides and fatty acids. These bioactive substances exhibit various biological activities, including antibiotic, antifungal, antiviral, and antitumor properties. This study aimed to isolate and identify a particular species of Bacillus from marine water and organisms that can produce bioactive secondary metabolites. Among the 73 Bacillus isolates collected, only 5 exhibited antagonistic activity against various viral and bacterial pathogens. The active isolates were subjected to 16S rRNA sequencing to determine their taxonomical affiliation. Among them, Bacillus tequilensis CCASU-2024-66 strain no. 42, with the accession number ON 054302 in GenBank, exhibited the highest inhibitory potential. It displayed an inhibition zone of 21 mm against Bacillus cereus while showing a minimum zone of inhibition of 9 mm against Escherichia coli and gave different inhibition against pathogenic fungi, the highest inhibition zone 15 mm against Candida albicans but the lowest inhibition zone 10 mm was against Botrytis cinerea, Fusarium oxysporum. Furthermore, it demonstrated the highest percentage of virucidal effect against the Newcastle virus and influenza virus, with rates of 98.6% and 98.1%, respectively. Furthermore, GC-MS analysis was employed to examine the bioactive substance components, specifically focusing on volatile and polysaccharide compounds. Based on these results, Bacillus tequilensis strain 42 may have the potential to be employed as an antiviral agent in poultry cultures to combat Newcastle and influenza, two extremely destructive viruses, thus reducing economic losses in the poultry production sector. Bacteria can be harnessed for the purpose of preserving food and controlling pathogenic fungi in both human and plant environments. Molecular docking for the three highly active derivatives 2,3-Butanediol, 2TMS, D-Xylopyranose, 4TMS, and Glucofuranoside, methyl 2,3,5,6-tetrakis-O-(trimethylsilyl) was carried out against the active sites of Bacillus cereus, Listeria monocytogenes, Candida albicans, Newcastle virus and influenza virus. The data obtained from molecular docking is highly correlated with that obtained from biology. Moreover, these highly active compounds exhibited excellent proposed ADMET profile.

Isolation of Secondary Metabolites with Antimicrobial Activities from Bacillus amyloliquefaciens LWYZ003

Natural Products from Bacillus Subtilis with Antimicrobial Properties

Isolation, Purification and Structure Determination of a Novel Antifungal Compound

Separation, Determination and Antifungal Activity Test of the Products from A New Bacillus Amyloliquefaciens

Isolation and Identification of Antibacterial Bioactive Compounds From Bacillus megaterium L2

Genomics and LC-MS Reveal Diverse Active Secondary Metabolites in Bacillus Amyloliquefaciens WS-8

Co-production of Multiple Antimicrobial Compounds by Bacillus Amyloliquefaciens WY047, a Strain with Broad-Spectrum Activity

Secondary Metabolites from the Mangrove-derived Fungus Trichoderma Sp.

A marine lipopeptides-producing Bacillus amyloliquefaciens HY2-1 with a broad-spectrum antifungal and antibacterial activity and its fermentation kinetics study

Assessment of antimicrobial activity and GC-MS using culture filtrate of local marine Bacillus strains

Fermentation Optimization,isolation and Identification of Tirandamycins A and B from Marine-Derived Streptomyces Sp.scsio 1666

Analysis of antimicrobial biological activity of a marine Bacillus velezensis NDB

Isolation and identification of secondary metabolites from marine-derived actinomycete WBF16

Genomics-guided Isolation and Identification of Active Secondary Metabolites of Bacillus Velezensis BA-26

Isolation of marine actinomycetes and studies on the secondary metabolites of strain Streptomyces sp. AH17-3

Analysis of the Genomic Sequences and Metabolites of Bacillus velezensis YA215

Secondary Metabolites of Two Marine-derived Mangrove Endophytic Fungi (Strains Nos. 1924# and 3893#) by Mixed Fermentation

Isolation and structure elucidation of the antibacterial metabolites from marine-derived Penicillium strain XGH2321

Screening of A Broad-Spectrum Antibacterial Bacillus and Purification and Identification of the Anti-Yeast Substances Produced by It

Antibacterial metabolites from the fermentation broth of marine fungus 095407

Targeted Isolation of Antibiofilm Compounds from Halophytic Endophyte Bacillus velezensis 7NPB-3B Using LC-HR-MS-Based Metabolomics